Mipsagargin is a recent generic drug that was created by GenSpera, Inc., a leader in developing therapies for cancer treatments.
This is a new drug that contains a natural product (a poisonous weed) that kills the growth of tumors.
Currently, Mipsagargin is in phase two clinical trials for hepatocellular carcinoma (liver cancer) and glioblastoma (brain cancer).
Will this drug be expanding to other cancer treatments?
Dr. Craig Dionne shares what Mipsagargin is and how patients can receive this drug for treatment.